An unprecedented FOUR SPACs expected to price their IPOs Thursday.
We’ve got a quadruple header…EdTechX, Arya Sciences, ChaSerg and Collier Creek are all expected to price their IPOs this evening for trading Friday. Suit up and get ready because another $730 million worth of SPACs are about to hit the market. Plus, that means our total 2018 deal count jumps to 37 with $8.952 billion in gross proceeds sold (before any up-sizes or over-allotments).
It will be interesting to see which ones upsize and how they trade tomorrow given that all four have different structures and focuses.
However, since we have an abundance of SPACs, the terms have been summarized below in a grid so you can compare, starting from smallest to largest.
We’ll be watching to see if anything changes, but as of right now, this is a record number of SPAC IPOs for one day. Exciting stuff…
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...